Qube Research & Technologies (QRT)’s Larimar Therapeutics LRMR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.01M	Buy	1,641,042 +793,398	+94%	+$3.15M	﹤0.01%	1629
2026 Q1	$3.81M	Buy	+847,644	New	+$3.39M	﹤0.01%	1803
2024 Q2	–	Sell	-89,094	Closed	-$676K	–	4354
2024 Q1	$676K	Buy	+89,094	New	+$694K	﹤0.01%	2371
2023 Q2	–	Sell	-45,782	Closed	-$207K	–	2741
2023 Q1	$207K	Buy	+45,782	New	+$239K	﹤0.01%	1924
2021 Q2	–	Sell	-11,123	Closed	-$163K	–	2580
2021 Q1	$163K	Sell	11,123 -31,800	-74%	-$578K	﹤0.01%	1683
2020 Q4	$919K	Buy	42,923 +5,278	+14%	+$106K	0.01%	901
2020 Q3	$571K	Buy	+37,645	New	+$477K	0.01%	987

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LRMR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Larimar Therapeutics (LRMR) stake by 94% in Q2 2026, buying an estimated $3.15M and bringing the position to 1,641,042 shares worth $5.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1629.

Qube Research & Technologies (QRT) first reported a position in LRMR in Q3 2020 and has held it in 7 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

Qube Research & Technologies (QRT) held 1,641,042 shares of Larimar Therapeutics worth $5.01M as of Q2 2026.
Qube Research & Technologies (QRT) bought 793,398 Larimar Therapeutics shares in Q2 2026, an estimated $3.15M.
Larimar Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1629 holding.
Qube Research & Technologies (QRT) first reported a position in Larimar Therapeutics in Q3 2020 and has held it in 7 quarters since.
163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.